Better Survival of Helicobacter pylori Infected Patients with Early Gastric Cancer Is Related to a Higher Level of Thomsen‐Friedenreich Antigen‐Specific Antibodies

References

• Appelmelk B. J., Simmons Smith I., Negrini R., Moran A., Aspinall G. O., Forte J. G., De Vries T., Quan H., Verboom T., Maaskant J. J., Ghiara P., Kuipers E. J., Bloemena E., Tadema T. M., Townsend R. R., Tyagarjan K., Crothers J. M., Monteiro M. A., Savio A., De Graf J. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 1996; 64: 2031–2040
   PubMed Web of Science ®Google Scholar
• Arany I., Adler‐Storthz K., Chen Z., Tyring S. K., Brysk H., Lei G., Brysk M. M. Local inflammation may influence oral tumor cell differentiation. Anticancer Res. 1999; 19(2A)1065–1067
   Google Scholar
• Baldus S. E., Hanish F.‐G. Biochemistry and pathological importance of mucin‐associated antigens in gastrointestinal neoplasia. Adv. Cancer Res. 2000; 79: 201–248
   PubMed Web of Science ®Google Scholar
• Bamford K. B., Fan X. J., Crowe S. E., Leary J. F., Gourley W. K., Luthra G. K., Brooks E. G., Graham D. Y., Reyes V. E., Ernst P. B. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a helper cell 1 phenotype. Gastroenterology 1998; 114: 482–492
   PubMed Web of Science ®Google Scholar
• Blaser M. J., Berg D. E. Helicobacter pylori genetic diversity and risk of human disease. J. Clin. Invest. 2001; 107: 767–773
   PubMed Web of Science ®Google Scholar
• Bontkes H. J., Veenendaal R. A., Pena A. S., Goedhard J. G., van Duijn W., Kuiper I. Meijer Jl & Lamers CBHW. IgG subclass response to Helicobacter pylori in patients with chronic active gastritis and duodenal ulcer. Scand. J. Gastroenterol. 1992; 27: 129–133
   PubMed Web of Science ®Google Scholar
• Chow W. H., Blaser M. J., Blot W. J., Gammon M. D., Vaughan T. L., Risch H. A., Perez‐Perez G. I., Schoenberg J. B., Stanford J. V., Rotterdam H., West A. B., Fraumeni J. F. An inverse relation between cagA + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998; 58: 588–590
   PubMed Web of Science ®Google Scholar
• Ernst P. B., Takaishi H., Crowe S. E. Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases. Dig Dis. 2001; 19: 104–111
   Google Scholar
• Faller G., Ruff N., Hochberger J., Hahn E. C., Kirchner T. Mucosal production of antigastric autoantibodies in Helicobacter pylori gastritis. Helicobacter 2000; 5: 129–134
   Google Scholar
• Glinsky V. V., Glinsky G. V., Rittenhouse‐Olson K., Huflejt M. E., Glinsky O. V., Deutscher S. L., Quinn T. P. The role of Thomsen‐Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res. 2001; 61: 4851–4857
   PubMed Web of Science ®Google Scholar
• Hamadeh R. M., Jarvis G. A., Zhou P., Cotleur A. C., Griffiss J. M. Bacterial enzymes can add galactose alpha1,3 to human erythrocytes and create a senecence‐associated epitope. Infect. Immun. 1996; 64: 528–534
   Google Scholar
• Jenkinson L., Bardhan K. D., Atherton J., Kalia N. Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: Role of cytokines. Dig. Dis. Sci. 2002; 47: 1857–1862
   Google Scholar
• Kang H. S., Cho D. H., Kim S. S., Pyun K. H., Choi I. Anti‐tumor effects of IL‐6 on murine liver tumor cells in vivo. J. Biomed. Sci. 1999; 6: 142–144
   Google Scholar
• Klaamas K., Held M., Wadstrom T., Lipping A., Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int. J. Cancer 1997; 9: 367–370
   Google Scholar
• Klaamas K., Kurtenkov O., Brjalin V., Miljukhina L., Shljapnikova L., Engstrand L. Enhanced humoral immune response to tumor‐associated T glycotope (Galβ1,3GalNAc) in Helicobacter pylori‐infected patients with gastric cancer and non‐tumor gastric diseases. Exp. Oncol. 2002a; 24: 38–44
   Google Scholar
• Klaamas K., Kurtenkov O., Rittenhouse‐Olson K., Brjalin V., Miljukhina L., Shljapnikova L., Engstrand L. Expression of tumor‐associated Thomsen‐Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals. Immunol. Invest. 2002b; 31: 191–204
   PubMed Web of Science ®Google Scholar
• Kuipers E. J. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment. Pharmacol. Ther. 1999; 13(Suppl. 1)3–11
   PubMedGoogle Scholar
• Kurtenkov O., Miljukhina L., Smorodin J., Klaamas K., Bovin N., Ellamaa M., Chuzmarov V. Natural IgM and IgG antibodies to thomsen‐Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors. Acta Oncol. 1999a; 38: 939–943
   PubMed Web of Science ®Google Scholar
• Kurtenkov O., Klaamas K., Miljukhina L., Shljapnikova L., Ellamaa M., Bovin N., Wadström T. IgG antibodies to Lewis type 2 antigens in serum of H. pylori‐infected and noninfected blood donors of different Lewis(a,b) blood‐group phenotype. FEMS Immunol. Med. Microbiol. 1999b; 24: 227–232
   Google Scholar
• Livingston P. O., Ragupathi G. Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans. Cancer Immunol. Immunother. 1997; 45: 10–19
   PubMed Web of Science ®Google Scholar
• Livingston P. O., Zhang S., Lloyd K. O. Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale. Cancer Immunol. Immunother. 1997; 45: 1–9
   PubMed Web of Science ®Google Scholar
• Loffeld R. J., Werdmuller B. F., Kuster J. G., Perez‐Perez G. I., Blaser M. J., Kuipers E. J. Colonization with cagA‐positive Helicobacter pylori strains inversly associated with reflux esophagitis and Barret's esophagus. Digestion 2000; 62: 95–99
   PubMedGoogle Scholar
• MacLean G. D., Bowen‐Yacyshyn M. B., Samuel J., Meikle A., Stuart G., Nation J., Poppema S., Jerry M., Koganty R., Wong T., Longenecker B. M. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen‐Friedenreich) determinant using syntyhetic carbohydrate antigen. J. Immunother. 1992; 11: 292–301
   PubMed Web of Science ®Google Scholar
• Nardone G., Staibano S., Rocco A., Mezza E., D'Armiento F. P., Insabato L., Coppola A., Salvatore G., Lucariello A., Figura N., De Rosa G., Budillon G. Effect of Helicobacter pylori infection and its eradication on cell proliferation; DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999; 44: 789–799
   PubMed Web of Science ®Google Scholar
• Negrini R., Saviuo A., Poiesi C., Appelmelk B. J., Buffoli F., Paterlini A., Cesari P., Graffeo M., Vaira D., Franzin G. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655–665
   PubMed Web of Science ®Google Scholar
• Pineros D.M. C., Riveros S.C. H., Marin J.D. M., Ricardo O., Diaz O. O. Helicobacter pylori in gastric cancer and peptic ulcer disease in a colombian population. Strain heterogeneity and antibody profiles. Helicobacter 2001; 6: 199–206
   Google Scholar
• Ren Z., Pang G., Lee R., Batey R., Dunkley M., Borody T., Clancy R. Circulating T‐cell response to Helicobacter pylori infection in chronic gastritis. Helicobacter 2000; 5: 135–141
   Google Scholar
• Rothenbacher D., Blaser M. J., Bode G., Brenner H. Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population‐based cross‐sectional study. J. Infect. Dis. 2000; 182: 1446–1449
   PubMedGoogle Scholar
• Sobin L. H., Wittekind C. H. TNM Classification of Malignant Tumors. UICC. N.Y. Willey. 1997
   Google Scholar
• Solnic J. V., Schauer D. B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enteroheaptic diseasees. Clin. Microbiol. Rev. 2001; 14: 59–97
   Google Scholar
• Springer G. F. T and Tn, general carcinoma autoantigens. Science 1984; 224: 1198–1206
   PubMed Web of Science ®Google Scholar
• Takanami I. Expression of Thomsen‐Friedenreich antgen as a marker of poor prognosis in pulmonary adenocarcinoma. Oncol. Rep. 1999; 6: 341–344
   PubMed Web of Science ®Google Scholar
• Tarkkanen J., Kosunen T. U., Saksela E. Contact of lymphocytes with helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect. Immun. 1993; 61: 3012–3016
   PubMedGoogle Scholar
• Vorobjova T., Faller G., Maaroos H.‐I., Sipponen P., Villako K., Uibo R., Kirchner T. Significant increase in antigastric autoantibodies in a long‐term follow‐up study of H. pylori gastritis. Virchows Arch. 2000; 437: 37–45
   PubMed Web of Science ®Google Scholar